ARIEL FERNANDO SORIANO
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- Sidney, NE
- NPI
- 1558345199
- Received
- $20,104 in 73 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 12 | $236 |
| 2024 | General payment | 9 | $1,283 |
| 2023 | General payment | 18 | $2,787 |
| 2022 | General payment | 9 | $2,127 |
| 2021 | General payment | 7 | $5,690 |
| 2020 | General payment | 13 | $7,879 |
| 2019 | General payment | 5 | $99 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $4,457 | 2020–2024 |
| PFIZER INC. | 4 | $3,020 | 2020–2025 |
| TAIHO ONCOLOGY, INC. | 2 | $2,930 | 2023–2024 |
| AstraZeneca Pharmaceuticals LP | 4 | $2,849 | 2020–2021 |
| SEAGEN INC. | 7 | $2,798 | 2021–2023 |
| GENZYME CORPORATION | 1 | $1,924 | 2020 |
| Daiichi Sankyo Inc. | 5 | $954 | 2022–2023 |
| Gilead Sciences, Inc. | 5 | $306 | 2021–2024 |
| Astellas Pharma US Inc | 9 | $235 | 2022–2025 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 | 2019–2025 |
| Merck Sharp & Dohme LLC | 3 | $67 | 2019–2024 |
| Janssen Biotech, Inc. | 4 | $63 | 2019–2025 |
| AngioDynamics, Inc. | 3 | $58 | 2025 |
| Amgen Inc. | 2 | $53 | 2019–2020 |
| Aveo Pharmaceuticals, Inc. | 2 | $37 | 2023–2025 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 | 2019–2020 |
| Adaptive Biotechnologies Corporation | 1 | $28 | 2023 |
| Myovant Sciences Inc. | 1 | $26 | 2021 |
| Iovance Biotherapeutics, Inc. | 1 | $23 | 2025 |
| Novartis Pharmaceuticals Corporation | 1 | $22 | 2022 |
| Teleflex LLC | 1 | $20 | 2022 |
| Pharmacyclics LLC, an AbbVie Company | 1 | $19 | 2020 |
| Myriad Genetic Laboratories, Inc. | 1 | $19 | 2020 |
| SOBI, INC | 1 | $19 | 2024 |
| Incyte Corporation | 1 | $18 | 2024 |
| Lilly USA, LLC | 1 | $16 | 2024 |
| Genentech USA, Inc. | 1 | $16 | 2025 |
| Foundation Medicine, Inc. | 1 | $11 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 8 | $14,654 |
| Honoraria | 3 | $3,430 |
| Food and Beverage | 52 | $1,357 |
| Travel and Lodging | 3 | $362 |
| Education | 7 | $300 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | Bayer Healthcare Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-10-23 | Aveo Pharmaceuticals, Inc. | $20 | Education | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-10-15 | AngioDynamics, Inc. | $26 | Food and Beverage | In-kind items and services | NANOKNIFE Device, OS | 2025 | |
| 2025-10-07 | AngioDynamics, Inc. | $17 | Food and Beverage | In-kind items and services | NANOKNIFE Device, OS | 2025 | |
| 2025-09-18 | AngioDynamics, Inc. | $15 | Food and Beverage | In-kind items and services | NANOKNIFE Device, OS | 2025 | |
| 2025-06-11 | Iovance Biotherapeutics, Inc. | $23 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-05-09 | Astellas Pharma US Inc | $22 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-05-08 | Astellas Pharma US Inc | $18 | Education | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-05-08 | Astellas Pharma US Inc | $18 | Education | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-04-02 | Genentech USA, Inc. | $16 | Food and Beverage | In-kind items and services | Itovebi Biological, BioOncology | 2025 | |
| 2025-02-12 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2025 | |
| 2025-01-06 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | TIVDAK Biological, ONCOLOGY | 2025 | |
| 2024-12-10 | Janssen Biotech, Inc. | $14 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-10-31 | TAIHO ONCOLOGY, INC. | $1,130 | Consulting Fee | Cash or cash equivalent | LONSURF Drug, Oncology | 2024 | |
| 2024-10-16 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-09-12 | SOBI, INC | $19 | Food and Beverage | In-kind items and services | VONJO Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-08-21 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-08-20 | Merck Sharp & Dohme LLC | $33 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-08-07 | Incyte Corporation | $18 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-07-18 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2024 | |
| 2024-06-04 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2023-12-13 | Daiichi Sankyo Inc. | $11 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2023 | |
| 2023-12-13 | Daiichi Sankyo Inc. | $4 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2023 | |
| 2023-12-12 | Aveo Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2023 | |
| 2023-12-06 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2023 | |
| 2023-12-04 | Daiichi Sankyo Inc. | $360 | Honoraria | Cash or cash equivalent | 2023 | ||
| 2023-11-14 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-11-07 | SEAGEN INC. | $99 | Education | In-kind items and services | 2023 | ||
| 2023-11-07 | SEAGEN INC. | $22 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2023 | |
| 2023-10-26 | Daiichi Sankyo Inc. | $28 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2023 | |
| 2023-10-12 | Adaptive Biotechnologies Corporation | $28 | Food and Beverage | Cash or cash equivalent | clonoSEQ Device, ONCOLOGY | 2023 | |
| 2023-08-24 | SEAGEN INC. | $24 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2023 | |
| 2023-08-08 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-05-18 | SEAGEN INC. | $37 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2023 | |
| 2023-04-20 | TAIHO ONCOLOGY, INC. | $1,800 | Consulting Fee | Cash or cash equivalent | LONSURF Drug, Oncology | 2023 | |
| 2023-02-24 | Gilead Sciences, Inc. | $125 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-02-24 | Gilead Sciences, Inc. | $93 | Travel and Lodging | In-kind items and services | 2023 | ||
| 2023-02-24 | Gilead Sciences, Inc. | $59 | Travel and Lodging | In-kind items and services | 2023 | ||
| 2023-01-17 | Astellas Pharma US Inc | $18 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2023 | |
| 2022-10-06 | Daiichi Sankyo Inc. | $550 | Honoraria | Cash or cash equivalent | 2022 | ||
| 2022-10-05 | Astellas Pharma US Inc | $66 | Education | In-kind items and services | 2022 | ||
| 2022-10-05 | Astellas Pharma US Inc | $64 | Education | In-kind items and services | 2022 | ||
| 2022-10-05 | Astellas Pharma US Inc | $10 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2022 | |
| 2022-09-15 | Teleflex LLC | $20 | Food and Beverage | In-kind items and services | ARROW Device, Interventional Access | 2022 | |
| 2022-08-11 | Astellas Pharma US Inc | $15 | Food and Beverage | In-kind items and services | PADCEV Drug, Oncology | 2022 | |
| 2022-08-11 | Astellas Pharma US Inc | $0 | Food and Beverage | In-kind items and services | PADCEV Drug, Oncology | 2022 | |
| 2022-05-17 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | KISQALI Drug, ONCOLOGY | 2022 | |
| 2022-04-28 | SEAGEN INC. | $1,375 | Consulting Fee | Cash or cash equivalent | TUKYSA Drug, Oncology | 2022 | |
| 2021-11-30 | GlaxoSmithKline, LLC. | $2,750 | Consulting Fee | Cash or cash equivalent | BLENREP Biological, ONCOLOGY | 2021 | |
| 2021-06-01 | Gilead Sciences, Inc. | $11 | Education | In-kind items and services | 2021 | ||
| 2021-03-31 | SEAGEN INC. | $14 | Food and Beverage | In-kind items and services | TUKYSA Drug, Oncology | 2021 | |
| 2021-03-17 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2021 | |
| 2021-02-11 | Myovant Sciences Inc. | $26 | Food and Beverage | In-kind items and services | ORGOVYX Drug, HORMONE THERAPY | 2021 | |
| 2021-02-03 | SEAGEN INC. | $1,225 | Consulting Fee | Cash or cash equivalent | ADCETRIS Biological, Oncology | 2021 | |
| 2021-01-12 | GlaxoSmithKline, LLC. | $1,650 | Consulting Fee | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2021 | |
| 2020-12-12 | GENZYME CORPORATION | $1,924 | Consulting Fee | Cash or cash equivalent | SARCLISA Biological, Oncology | 2020 | |
| 2020-10-05 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2020 | |
| 2020-09-28 | Myriad Genetic Laboratories, Inc. | $19 | Food and Beverage | Cash or cash equivalent | BRACANALYSIS CDX Device, GERMLINE DNA SEQUENCING HEREDITARY CANCER AND REARRANGEMENT ANALYSIS | 2020 | |
| 2020-07-28 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | IMFINZI Drug, Oncology | 2020 | |
| 2020-06-25 | AstraZeneca Pharmaceuticals LP | $2,800 | Consulting Fee | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2020 | |
| 2020-03-19 | PFIZER INC. | $2,520 | Honoraria | Cash or cash equivalent | RUXIENCE Biological, ONCOLOGY | 2020 | |
| 2020-02-26 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | Kyprolis Drug, Oncology | 2020 | |
| 2020-02-21 | PFIZER INC. | $274 | Food and Beverage | In-kind items and services | RUXIENCE Biological, ONCOLOGY | 2020 | |
| 2020-02-21 | PFIZER INC. | $209 | Travel and Lodging | In-kind items and services | RUXIENCE Biological, ONCOLOGY | 2020 | |
| 2020-02-11 | Foundation Medicine, Inc. | $11 | Food and Beverage | In-kind items and services | FOUNDATIONONE Device, ONCOLOGY | 2020 | |
| 2020-02-05 | Pharmacyclics LLC, an AbbVie Company | $19 | Food and Beverage | In-kind items and services | Imbruvica Drug, Oncology | 2020 | |
| 2020-01-30 | Ipsen Biopharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | SOMATULINE DEPOT Drug, Oncology/Endocrinology | 2020 | |
| 2020-01-27 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | IMFINZI Drug, Oncology | 2020 | |
| 2019-12-18 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | LENVIMA Drug, ONCOLOGY | 2019 | |
| 2019-12-10 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2019 | |
| 2019-09-23 | Amgen Inc. | $28 | Food and Beverage | In-kind items and services | Kyprolis Biological, Oncology | 2019 | |
| 2019-08-22 | Ipsen Biopharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SOMATULINE DEPOT Drug, Oncology/Endocrinology | 2019 | |
| 2019-04-09 | Bayer Healthcare Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | Xofigo Drug, Oncology | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Sidney, NE, county Cheyenne County, NE, state Nebraska; placed by its city name.
| Measure | Place (city or town) Sidney, NE | County Cheyenne County, NE | State Nebraska |
|---|---|---|---|
| Population B01003 | 6,419 | 9,533 | 1,978,707 |
| Population, 2020 census P1 | 6,410 | 9,468 | 1,961,504 |
| Median age B01002 | 41.9 | 42.5 | 37.2 |
| Under 18 B01001 | 20.6% | 21.8% | 24.5% |
| 65 and over B01001 | 21.0% | 22.0% | 16.7% |
| Households B11001 | 3,113 | 4,464 | 797,847 |
| Foreign born B05002 | 1.8% | 1.7% | 8.0% |
| Median household income B19013 | $54,734 | $60,348 | $76,475 |
| Median family income B19113 | $71,250 | $80,250 | $99,751 |
| Per capita income B19301 | $32,095 | $35,747 | $41,751 |
| Poverty rate B17001 | 16.2% | 14.3% | 10.6% |
| Unemployment rate B23025 | 3.1% | 3.4% | 3.0% |
| Civilian labor force B23025 | 3,361 | 4,931 | 1,056,746 |
| Mean commute (minutes) B08013 | 13.3 | 16.3 | 19.2 |
| Bachelor's degree or higher B15003 | 19.5% | 23.2% | 34.6% |
| Housing units B25001 | 3,248 | 4,888 | 863,444 |
| Owner-occupied B25003 | 57.5% | 66.7% | 66.5% |
| Renters B25003 | 42.5% | 33.3% | 33.5% |
| Median home value B25077 | $139,400 | $139,700 | $238,600 |
| Median gross rent B25064 | $819 | $821 | $1,072 |
| White, not Hispanic B03002 | 84.0% | 86.9% | 75.3% |
| Black B03002 | 1.1% | 0.8% | 4.6% |
| Hispanic or Latino B03002 | 10.4% | 8.7% | 12.7% |
| Asian B03002 | 1.9% | 1.3% | 2.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Sidney, NE.
Comments